Friday, May 29, 2009
The annual International Symposium on Malignant Mesothelioma is now less than a month away. An annual symposium organized by the Mesothelioma Applied Research Foundation, a charitable organization, will bring together international experts in asbestos-related cancers. patients and caregivers June 25-27 in Washington, D.C. to discuss the latest advances in mesothelioma research.For more information on reserving your spot for one of the largest events concerning mesothelioma, its treatment, and the people involved, please visit the MARF website for
more information.
Labels: Cancer, Family, Mesothelioma, National News, Patients, Treatments
posted by Aaron Phelps at 11:50 PM
News Categories
Contributing Author
Wade Rawlins is a former environmental reporter with the Raleigh News & Observer.
Editorial Board
- Mike Dayton, Editor
- Nancy Meredith, Writer
- Aaron Phelps, Writer
- Lisa Vaughn, Contributor
Resources For Living
Mesothelioma Forum
Legal Help Blog
Mesothelioma Blog
Find a Doctor Near You
Latest News
- Asbestos Linked to Larynx and Ovarian Cancers
- Canadian Expert Surprised Over Delay in Publishin...
- New Mesothelioma Treatment Shows Promise
- Eli Lilly to Reveal Study Data on Mesothelioma Dru...
- Britain's Prime Minister Vows to Tackle Asbestos C...
- Swine Flu and Mesothelioma Patients
- Bishop Loses Battle with Mesothelioma
- Over $10 Billion to Fund National Institutes of He...
- Gene Test Predicts Mesothelioma Survival
- Workers' Memorial May Bring Awareness to Mesotheli...
News Archives
Get Help Today
TODAY’S DATE:
YOUR ONLINE RESOURCE FOR NEWS ABOUT MESOTHELIOMA
-
FEATURED NEWS
Researchers Seek Antibodies that Predict Mesotheli...
By Wade Rawlins
>READ MORE
Doctors often have difficulty distinguishing whether a patient has malignant mesothelioma, a cancer that affects the lining of the lung, or adenocarcinoma, a type of cancer th... -
INTERNATIONAL NEWS
Immunotherapy Targets Can...
Researchers in the Netherlands have shown for the first time the feasibility of using dendritic-cell based immunotherapy in the tr...
>READ MORE